SoftOx Solutions AS
SOFTX | OL
Overview
Corporate Details
- ISIN(s):
- NO0010811961 (+2 more)
- LEI:
- 549300AETMWJS91G4A50
- Country:
- Norway
- Address:
- Martin Linges vei 25, 1364 Fornebu
- Website:
- https://soft-ox.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
SoftOx Solutions AS is a Scandinavian medtech/biotech company, founded in 2012. After years of research and product development with leading Nordic research institutions, SoftOx has developed a non-toxic and highly efficient antiseptic technology, which eradicates and prevents biofilm infections and is fully virucidal. The unique SoftOx technology, developed in close collaboration with expert scientists and clinicians from the universities in Skåne County and the University of Copenhagen, is based on a combination of naturally occurring chemicals that harbour broad antimicrobial effects without inducing resistance.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-13 08:02 |
Regulatory News Service
SoftOx Solutions AS: Notice of Annual General Assembly - Attachment: Call Gener…
|
English | 2.8 MB | |
| 2025-06-13 08:02 |
General Meeting Notice
SoftOx Solutions AS: Notice of Annual General Assembly
|
English | 1.4 KB | |
| 2025-06-12 15:08 |
Report Publication Announcement
Financial calendar
|
English | 689 bytes | |
| 2025-05-30 08:00 |
Board/Management Change
SoftOx Solutions AS: Board Member Resignations
|
English | 1.2 KB | |
| 2025-05-27 08:00 |
Annual Report
SoftOx Solutions AS: Annual Report 2024 - Attachment: SoftOx Solution - Annual …
|
English | 1.4 MB | |
| 2025-05-27 08:00 |
Report Publication Announcement
SoftOx Solutions AS: Annual Report 2024
|
English | 1.2 KB | |
| 2025-05-23 12:07 |
Report Publication Announcement
Financial calendar
|
English | 719 bytes | |
| 2025-04-09 13:30 |
Regulatory News Service
SoftOx Solutions AS: New Share Capital
|
English | 1.5 KB | |
| 2025-03-26 07:00 |
Regulatory News Service
SoftOx Solutions AS: Fourth Quarter Report 2024
|
English | 1.1 MB | |
| 2025-03-26 07:00 |
Regulatory News Service
SoftOx Solutions AS: Fourth Quarter Report 2024
|
English | 337 bytes | |
| 2025-03-25 09:16 |
Inside Information Statement
SoftOx Solutions AS: Private Placement resolved
|
Norwegian | 3.6 KB | |
| 2025-03-24 08:23 |
Inside Information Statement
SoftOx Solutions AS: Contemplated Private Placement
|
English | 3.9 KB | |
| 2025-02-27 21:52 |
Regulatory News Service
SoftOx Solutions AS: Settlement of legal dispute
|
English | 1.2 KB | |
| 2025-02-26 11:33 |
Regulatory News Service
SoftOx Solutions AS: Settlement of legal dispute
|
English | 1.2 KB | |
| 2025-02-25 11:36 |
Regulatory News Service
Financial calendar
|
English | 757 bytes |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
NanoGroup S.A. | Poland | NNG | |
|
Nattaro Labs AB | Sweden | NATTA | |
|
Neovacs | France | ALNEV | |
|
Newron Pharmaceuticals S.p.A. | Italy | NWRN | |
|
NextCell Pharma AB | Sweden | NXTCL | |
|
NextFerm Technologies Ltd. | Israel | NXFR | |
|
NFL Biosciences | France | ALNFL | |
|
Nortem BioGroup | Spain | MLBIO | |
|
Novo Nordisk | Denmark | NOVO | |
|
NRGene Technologies Ltd. | Israel | NRGN |